It doesn't matter whether Provista cancelled that agreement or not. DR-70 is now off patent. Without patent protection that agreement is worthless.
Assume that this Provista 5-year agreement was never cancelled and assume that you want to manufacture and sell DR-70 today. Nobody has protected intellectual property to take into court and stop you.
Nobody can stop Gartner from doing this at GCDx either.
The problem is.... DR-70 has failed to turn a profit since Radient first tried marketing it in Brazil in 1995. IMO, the test isn't getting better or more relevant with age -- it's getting more obsolete.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.